A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Astrazeneca PLC stock. As of the latest transaction made, Bridgewater Associates, LP holds 205,108 shares of AZN stock, worth $13.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
205,108
Previous 209,177 1.95%
Holding current value
$13.4 Million
Previous $16.3 Million 2.03%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $311,970 - $356,525
-4,069 Reduced 1.95%
205,108 $16 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $7.34 Million - $8.88 Million
109,915 Added 110.73%
209,177 $16.3 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $3.71 Million - $4.23 Million
-60,788 Reduced 37.98%
99,262 $6.73 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $2.86 Million - $3.2 Million
46,241 Added 40.63%
160,050 $10.8 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $262,512 - $290,241
4,048 Added 3.69%
113,809 $7.71 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $849,336 - $921,015
12,149 Added 12.45%
109,761 $7.86 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $504,821 - $572,370
7,994 Added 8.92%
97,612 $6.78 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $532,721 - $692,213
9,827 Added 12.32%
89,618 $6.08 Million
Q3 2022

Nov 10, 2022

BUY
$53.02 - $135.75 $465,992 - $1.19 Million
8,789 Added 12.38%
79,791 $4.38 Million
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $330,907 - $397,245
-5,584 Reduced 7.29%
71,002 $4.69 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $205,829 - $247,941
3,694 Added 5.07%
76,586 $5.08 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $1.69 Million - $2 Million
-31,341 Reduced 30.07%
72,892 $4.25 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $716,557 - $784,008
12,897 Added 14.12%
104,233 $6.26 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $4.42 Million - $5.5 Million
91,336 New
91,336 $5.47 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.